{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:07:22Z","timestamp":1789672042823,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T00:00:00Z","timestamp":1265068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/cr.2010.20","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T11:42:29Z","timestamp":1265110949000},"page":"345-356","source":"Crossref","is-referenced-by-count":110,"title":["Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE\/IRP dependent"],"prefix":"10.1038","volume":"20","author":[{"given":"Hong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,2]]},"reference":[{"key":"BFcr201020_CR1","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/mds.21020","volume":"21","author":"D Berg","year":"2006","unstructured":"Berg D, Hochstrasser H . Iron metabolism in Parkinsonian syndromes. Mov Disord 2006; 21:1299\u20131310.","journal-title":"Mov Disord"},{"key":"BFcr201020_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/01.rmr.0000245461.90406.ad","volume":"17","author":"D Berg","year":"2006","unstructured":"Berg D, Youdim MB . Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 2006; 17:5\u201317.","journal-title":"Top Magn Reson Imaging"},{"key":"BFcr201020_CR3","first-page":"571","volume":"55","author":"H Jiang","year":"2003","unstructured":"Jiang H, Qian ZM, Xie JX . [Increased DMT1 expression and iron content in MPTP-treated C57BL\/6 mice]. Sheng Li Xue Bao 2003; 55:571\u2013576.","journal-title":"Sheng Li Xue Bao"},{"key":"BFcr201020_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0014-4886(03)00057-8","volume":"182","author":"JX Xie","year":"2003","unstructured":"Xie JX, Jiang H, Chen WF, Qian ZM . Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease. Exp Neurol 2003; 182:483\u2013489.","journal-title":"Exp Neurol"},{"key":"BFcr201020_CR5","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","volume":"70","author":"WR Martin","year":"2008","unstructured":"Martin WR, Wieler M, Gee M . Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008; 70 (Pt 2):1411\u20131417.","journal-title":"Neurology"},{"key":"BFcr201020_CR6","doi-asserted-by":"publisher","first-page":"18578","DOI":"10.1073\/pnas.0804373105","volume":"105","author":"J Salazar","year":"2008","unstructured":"Salazar J, Mena N, Hunot S, et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci USA 2008; 105:18578\u201318583.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr201020_CR7","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s11064-004-7031-5","volume":"29","author":"J Wang","year":"2004","unstructured":"Wang J, Jiang H, Xie JX . Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system. Neurochem Res 2004; 29:2239\u20132243.","journal-title":"Neurochem Res"},{"key":"BFcr201020_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1196\/annals.1306.025","volume":"1012","author":"MB Youdim","year":"2004","unstructured":"Youdim MB, Stephenson G, Ben Shachar D . Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann N Y Acad Sci 2004; 1012:306\u2013325.","journal-title":"Ann N Y Acad Sci"},{"key":"BFcr201020_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"L Zecca","year":"2004","unstructured":"Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR . Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004; 5:863\u2013873.","journal-title":"Nat Rev Neurosci"},{"key":"BFcr201020_CR10","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","volume":"68","author":"AE Oakley","year":"2007","unstructured":"Oakley AE, Collingwood JF, Dobson J, et al. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 2007; 68:1820\u20131825.","journal-title":"Neurology"},{"key":"BFcr201020_CR11","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1002\/jnr.21430","volume":"85","author":"N Song","year":"2007","unstructured":"Song N, Jiang H, Wang J, Xie JX . Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. J Neurosci Res 2007; 85:3118\u20133126.","journal-title":"J Neurosci Res"},{"key":"BFcr201020_CR12","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.neurobiolaging.2007.11.025","volume":"30","author":"S Zhang","year":"2009","unstructured":"Zhang S, Wang J, Song N, Xie J, Jiang H . Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Neurobiol Aging 2009; 30:1466\u20131476.","journal-title":"Neurobiol Aging"},{"key":"BFcr201020_CR13","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.1073\/pnas.93.16.8175","volume":"93","author":"MW Hentze","year":"1996","unstructured":"Hentze MW, Kuhn LC . Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 1996; 93:8175\u20138182.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr201020_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1046\/j.1471-4159.2002.00971.x","volume":"82","author":"C Nunez-Millacura","year":"2002","unstructured":"Nunez-Millacura C, Tapia V, Munoz P, Maccioni RB, Nunez MT . An oxidative stress-mediated positive-feedback iron uptake loop in neuronal cells. J Neurochem 2002; 82:240\u2013248.","journal-title":"J Neurochem"},{"key":"BFcr201020_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.nbd.2008.04.008","volume":"31","author":"RF Regan","year":"2008","unstructured":"Regan RF, Chen M, Li Z, et al. Neurons lacking iron regulatory protein-2 are highly resistant to the toxicity of hemoglobin. Neurobiol Dis 2008; 31:242\u2013249.","journal-title":"Neurobiol Dis"},{"key":"BFcr201020_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbrc.2008.07.061","volume":"375","author":"RF Regan","year":"2008","unstructured":"Regan RF, Li Z, Chen M, Zhang X, Chen-Roetling J . Iron regulatory proteins increase neuronal vulnerability to hydrogen peroxide. Biochem Biophys Res Commun 2008; 375:6\u201310.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcr201020_CR17","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1074\/jbc.M709043200","volume":"283","author":"BJ Niles","year":"2008","unstructured":"Niles BJ, Clegg MS, Hanna LA, et al. Zinc deficiency-induced iron accumulation, a consequence of alterations in iron regulatory protein-binding activity, iron transporters, and iron storage proteins. J Biol Chem 2008; 283:5168\u20135177.","journal-title":"J Biol Chem"},{"key":"BFcr201020_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"175","author":"R Deumens","year":"2002","unstructured":"Deumens R, Blokland A, Prickaerts J . Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 2002; 175:303\u2013317.","journal-title":"Exp Neurol"},{"key":"BFcr201020_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.brainres.2008.01.089","volume":"1203","author":"TM Kaariainen","year":"2008","unstructured":"Kaariainen TM, Piltonen M, Ossola B, et al. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. Brain Res 2008; 1203:149\u2013159.","journal-title":"Brain Res"},{"key":"BFcr201020_CR20","doi-asserted-by":"publisher","first-page":"34479","DOI":"10.1074\/jbc.M705426200","volume":"282","author":"Z Weng","year":"2007","unstructured":"Weng Z, Signore AP, Gao Y, et al. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem 2007; 282:34479\u201334491.","journal-title":"J Biol Chem"},{"key":"BFcr201020_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/WNR.0b013e32821c51fe","volume":"18","author":"ZG Ma","year":"2007","unstructured":"Ma ZG, Wang J, Jiang H, Liu TW, Xie JX . Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats. Neuroreport 2007; 18:1181\u20131185.","journal-title":"Neuroreport"},{"key":"BFcr201020_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2165\/00023210-200317100-00004","volume":"17","author":"S Mandel","year":"2003","unstructured":"Mandel S, Grunblatt E, Riederer P, et al. Neuroprotective strategies in Parkinson's disease: an update on progress. CNS Drugs 2003; 17:729\u2013762.","journal-title":"CNS Drugs"},{"key":"BFcr201020_CR23","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1523\/JNEUROSCI.12-09-03392.1992","volume":"12","author":"GD Crawford Jr","year":"1992","unstructured":"Crawford GD Jr, Le WD, Smith RG, et al. A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci 1992; 12:3392\u20133398.","journal-title":"J Neurosci"},{"key":"BFcr201020_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.neuint.2006.04.015","volume":"49","author":"H Jiang","year":"2006","unstructured":"Jiang H, Luan Z, Wang J, Xie J . Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 2006; 49:605\u2013609.","journal-title":"Neurochem Int"},{"key":"BFcr201020_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neuropharm.2003.09.005","volume":"46","author":"DB Shachar","year":"2004","unstructured":"Shachar DB, Kahana N, Kampel V, Warshawsky A, Youdim MB . Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology 2004; 46:254\u2013263.","journal-title":"Neuropharmacology"},{"key":"BFcr201020_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2008.03.091","volume":"155","author":"L Wang","year":"2008","unstructured":"Wang L, Wang W, Zhao M, Ma L, Li M . Psychological stress induces dysregulation of iron metabolism in rat brain. Neuroscience 2008; 155:24\u201330.","journal-title":"Neuroscience"},{"key":"BFcr201020_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cmet.2007.10.006","volume":"7","author":"B Galy","year":"2008","unstructured":"Galy B, Ferring-Appel D, Kaden S, Grone HJ, Hentze MW . Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab 2008; 7:79\u201385.","journal-title":"Cell Metab"},{"key":"BFcr201020_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00221-005-0220-x","volume":"170","author":"E Huang","year":"2006","unstructured":"Huang E, Ong WY, Go ML, Connor JR . Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury. Exp Brain Res 2006; 170:376\u2013386.","journal-title":"Exp Brain Res"},{"key":"BFcr201020_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.exphem.2007.03.005","volume":"35","author":"J Kato","year":"2007","unstructured":"Kato J, Kobune M, Ohkubo S, et al. Iron\/IRP-1-dependent regulation of mRNA expression for transferrin receptor, DMT1 and ferritin during human erythroid differentiation. Exp Hematol 2007; 35:879\u2013887.","journal-title":"Exp Hematol"},{"key":"BFcr201020_CR30","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1046\/j.1471-4159.1998.70062492.x","volume":"70","author":"KL Double","year":"1998","unstructured":"Double KL, Maywald M, Schmittel M, Riederer P, Gerlach M . In vitro studies of ferritin iron release and neurotoxicity. J Neurochem 1998; 70:2492\u20132499.","journal-title":"J Neurochem"},{"key":"BFcr201020_CR31","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1126\/science.172.3989.1257","volume":"172","author":"R Heikkila","year":"1971","unstructured":"Heikkila R, Cohen G . Inhibition of biogenic amine uptake by hydrogen peroxide: a mechanism for toxic effects of 6-hydroxydopamine. Science 1971; 172:1257\u20131258.","journal-title":"Science"},{"key":"BFcr201020_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0026-895X(25)12658-8","volume":"7","author":"A Saner","year":"1971","unstructured":"Saner A, Thoenen H . Model experiments on the molecular mechanism of action of 6-hydroxydopamine. Mol Pharmacol 1971; 7:147\u2013154.","journal-title":"Mol Pharmacol"},{"key":"BFcr201020_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0304-3940(00)00948-4","volume":"283","author":"D Blum","year":"2000","unstructured":"Blum D, Torch S, Nissou MF, Benabid AL, Verna JM . Extracellular toxicity of 6-hydroxydopamine on PC12 cells. Neurosci Lett 2000; 283:193\u2013196.","journal-title":"Neurosci Lett"},{"key":"BFcr201020_CR34","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1074\/jbc.M511560200","volume":"281","author":"K Hanrott","year":"2006","unstructured":"Hanrott K, Gudmunsen L, O'Neill MJ, Wonnacott S . 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem 2006; 281:5373\u20135382.","journal-title":"J Biol Chem"},{"key":"BFcr201020_CR35","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1128\/MCB.16.7.3781","volume":"16","author":"K Pantopoulos","year":"1996","unstructured":"Pantopoulos K, Weiss G, Hentze MW . Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways. Mol Cell Biol 1996; 16:3781\u20133788.","journal-title":"Mol Cell Biol"},{"key":"BFcr201020_CR36","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1128\/MCB.24.3.954-965.2004","volume":"24","author":"J Wang","year":"2004","unstructured":"Wang J, Chen G, Muckenthaler M, et al. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol Cell Biol 2004; 24:954\u2013965.","journal-title":"Mol Cell Biol"},{"key":"BFcr201020_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000147312","volume":"144","author":"CM Morris","year":"1992","unstructured":"Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA . Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) 1992; 144:235\u2013257.","journal-title":"Acta Anat (Basel)"},{"key":"BFcr201020_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00228642","volume":"109","author":"CD Earl","year":"1996","unstructured":"Earl CD, Reum T, Xie JX, et al. Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson's disease: in vivo voltammetric data. Exp Brain Res 1996; 109:179\u2013184.","journal-title":"Exp Brain Res"},{"key":"BFcr201020_CR39","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1111\/j.1460-9568.2007.05515.x","volume":"25","author":"J Wang","year":"2007","unstructured":"Wang J, Jiang H, Xie JX . Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats. Eur J Neurosci 2007; 25:2766\u20132772.","journal-title":"Eur J Neurosci"},{"key":"BFcr201020_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0006-8993(01)02935-3","volume":"917","author":"Y Zhou","year":"2001","unstructured":"Zhou Y, Zhao ZQ, Xie JX . Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats. Brain Res 2001; 917:127\u2013132.","journal-title":"Brain Res"},{"key":"BFcr201020_CR41","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.expneurol.2008.05.006","volume":"212","author":"H Jiang","year":"2008","unstructured":"Jiang H, Li LJ, Wang J, Xie JX . Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp Neurol 2008; 212:532\u2013537.","journal-title":"Exp Neurol"},{"key":"BFcr201020_CR42","doi-asserted-by":"publisher","first-page":"24209","DOI":"10.1074\/jbc.270.41.24209","volume":"270","author":"W Breuer","year":"1995","unstructured":"Breuer W, Epsztejn S, Cabantchik ZI . Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J Biol Chem 1995; 270:24209\u201324215.","journal-title":"J Biol Chem"},{"key":"BFcr201020_CR43","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0006-2952(99)00040-4","volume":"57","author":"JM May","year":"1999","unstructured":"May JM, Qu ZC, Mendiratta S . Role of ascorbic acid in transferrin-independent reduction and uptake of iron by U-937 cells. Biochem Pharmacol 1999; 57:1275\u20131282.","journal-title":"Biochem Pharmacol"},{"key":"BFcr201020_CR44","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.chembiol.2006.08.005","volume":"13","author":"HA Wetli","year":"2006","unstructured":"Wetli HA, Buckett PD, Wessling-Resnick M . Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake. Chem Biol 2006; 13:965\u2013972.","journal-title":"Chem Biol"},{"key":"BFcr201020_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tox.2004.06.008","volume":"203","author":"T Armeni","year":"2004","unstructured":"Armeni T, Damiani E, Battino M, Greci L, Principato G . Lack of in vitro protection by a common sunscreen ingredient on UVA-induced cytotoxicity in keratinocytes. Toxicology 2004; 203:165\u2013178.","journal-title":"Toxicology"},{"key":"BFcr201020_CR46","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1158\/0008-5472.CAN-05-2656","volume":"66","author":"L Xue","year":"2006","unstructured":"Xue L, Zhou B, Liu X, et al. Structurally dependent redox property of ribonucleotide reductase subunit p53R2. Cancer Res 2006; 66:1900\u20131905.","journal-title":"Cancer Res"}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cr201020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr201020","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr201020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T06:06:06Z","timestamp":1739772366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cr201020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,2]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["BFcr201020"],"URL":"https:\/\/doi.org\/10.1038\/cr.2010.20","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,2]]}}}